Device Trial Radar · NCT03752151
Micra Atrial TRacking Using A Ventricular AccELerometer 2
Last checked: Nov 19, 2026Latest source record: Jun 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
77
Actual
Start
Jan 22, 2019
Primary completion
Aug 7, 2019
Study completion Aug 7, 2019
Sponsor
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
- Sponsor type
- Industry
- First posted
- Nov 23, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the Micra Atrial TRacking Using A Ventricular AccELerometer 2 (MARVEL 2) study is to demonstrate safe and effective operation of the MARVEL 2 features for providing AV synchronous pacing in patients with normal sinus node function and AV block
Conditions
- Atrioventricular Conduction Block
Interventions
MARVEL 2 Algorithm Monitor Mode then Adaptive ModeDevice
Software download into implanted Micra device and programmed to MARVEL 2 Monitor Mode then MARVEL 2 Adaptive Mode
Primary outcomes
What the sponsor says the trial is designed to measure.
- Atrial Ventricular Pacing Synchrony Success During RestTime frame: 40 Minutes
- Number of Participants Free From Inappropriate Pacemaker Function EventsTime frame: Through study completion an average of one day
Locations
12 sites in 8 countries. Site status is shown where the registry gives one.
Baptist Medical Center Jacksonville
Jacksonville, Florida
Baptist Hospital
Miami, Florida
North Shore University Hospital- Northwell
Manhasset, New York
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.